A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms EKVASIS
- 19 Aug 2014 Biomarkers information updated
- 20 Feb 2013 Planned initiation date changed from 1 Jan 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 01 Feb 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.